According to a Health Canada approval announced by Novo Nordisk on March 2, 2026, the new indication is based on a pooled analysis of four large clinical trials: SUSTAIN 6, PIONEER 6, FLOW, and SOUL
I've talked with many people considering whether or not taking a GLP-1 medication is right for them, and I've seen many people be successful on them
Due to their high reactivity, ROS typically oxidize targets with or adjacent to the intracellular compartment where they are produced, affecting surrounding neighboring cells
Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment
Understanding the differences between these medications, including how they affect metabolism, appetite, and overall weight management, can help patients make informed decisions